Type 2 Herpes Simplex Virus and Vulvar Carcinoma in Situ
- 27 August 1981
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 305 (9) , 517-518
- https://doi.org/10.1056/nejm198108273050910
Abstract
Squamous-cell carcinoma in situ (CIS) of the vulva is now being reported at an increasing frequency. Its association with cervical CIS and invasive cancer has been recognized, and a "field effect" has been proposed to explain cases of CIS of the vulva, vagina, and cervix as responses to a common stimulus.1 , 2 Furthermore, genital CIS lesions are often multicentric. These disorders are especially alarming to patients, since CIS of the cervix can progress to invasive cancer. One topical and especially noteworthy candidate for the role of a common carcinogenic stimulus is herpes simplex virus Type 2 (HSV2), which has been associated . . .Keywords
This publication has 5 references indexed in Scilit:
- Herpesvirus-Induced Antigens in Squamous-Cell Carcinoma in Situ of the VulvaNew England Journal of Medicine, 1981
- The significance of the histologic alterations adjacent to invasive vulvar carcinomaAmerican Journal of Obstetrics and Gynecology, 1980
- Carcinoma in situ of the vulva: A continuing challengeAmerican Journal of Obstetrics and Gynecology, 1980
- On the Etiology and Prevention of Cervical Cancer—A Status ReportObstetrical & Gynecological Survey, 1979
- The contemporary challenge of carcinoma in situ of the vulvaAmerican Journal of Obstetrics and Gynecology, 1973